Within the bounds of risk-based quality management, the utilization of predefined Quality Tolerance Limits (QTLs) is a way to control quality and risk in clinical trials. QTLs identify systematic risks to patients and data integrity at the study level. We've listed the 7 most commonly used QTLs that are applicable to most trials.
Learn how risk-based quality management (RBQM) helps simplify coronavirus vaccine development and helps mitigate any unnecessary burden from clinical organizations ensuring vaccines are readily available when needed.
Can machine learning bring about innovative transformation to the pharmaceutical industry? Join Artem Andrianov, PhD, who will be speaking about the power of ML-driven predictive analytics in risk-based quality management, at this co-hosted FREE event by Oracle and Applied Clinical Trials.
Are you an orphan expert? Do you care about rare? We invite you to collaborate with us on a rare disease-focused RACT that will help reveal and address orphan drug trial risks more efficiently.
On Day 1, join Our Chief Scientific Officer, Dr Johann Proeve as he speaks about the Leadership perspective of Change Management. Stay tuned on Day 2, as our CEO Dr Artem Andrianov discusses Innovative Approaches to Remote Monitoring during & post COVID-19 with other industry experts!
We've documented real-life case studies for you, illustrating how the MyRBQM® Portal helped address common risks using the principles of risk-based quality management.
We've documented real-life case studies for you, illustrating how the MyRBQM® Portal helped address common risks using the principles of risk-based quality management.
We've documented real-life case studies for you, illustrating how the MyRBQM® Portal helped address common risks using the principles of risk-based quality management.
We've documented real-life case studies for you, illustrating how the MyRBQM® Portal helped address common risks using the principles of risk-based quality management.
Artem Andrianov, PhD, our CEO, will be one of the key-note speakers at the CMPRR virtual summit organized by KP Morgan. Artem will be speaking about Risk-based Quality Management, i.e. the role of technology in accelerating the clinical trials process.
